Freya joined SV in 2022 and is an Associate in the biotech team. She helps form and fund companies developing transformational new medicines. Freya serves as a Board Observer at Mestag Therapeutics.
Prior to joining SV, Freya worked as a Healthcare Analyst at Farallon Capital Management between San Francisco and London where she led and supported on investments across the biotech and pharma space. Outside of SV, Freya is a yoga enthusiast, avid traveller, and a lover of coffee and natural history.
BA (Hons) in Biological Sciences from Magdalen College, Oxford
MPhil in Bioscience Enterprise from Churchill College, Cambridge